Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Pfizer withdraws sickle cell drug Oxbryta
Pfizer pulls sickle cell drug oxbryta, raising safety concerns
Pfizer’s abrupt withdrawal of Oxbryta, a drug for sickle cell disease, has sent shockwaves through the medical community.
Pfizer's Oxbryta exit may hasten trials of rival experimental sickle cell drugs, analysts say
Pfizer's decision late on Wednesday to withdraw its sickle cell disease treatment due to the risk of death could help speed up trials of new experimental rivals, Wall Street analysts said.
Pfizer’s Oxbryta Withdrawal Leaves Sickle Cell Community Scrambling, Investors Reeling
Pfizer’s sudden market withdrawal of sickle cell therapy Oxbryta, which some analysts predicted would reach $750 million in sales by the end of the decade, has left patients and healthcare providers with few options,
2d
on MSN
FDA alerts patients about Pfizer's Oxbryta withdrawal
The U.S. Food and Drug Administration on Thursday alerted patients and healthcare professionals about the withdrawal of ...
3d
Pfizer to Withdraw Sickle-Cell Drug Oxbryta From Worldwide Markets
The healthcare company said clinical data indicates the overall benefit of Oxbryta no longer outweighs the risk in the ...
devdiscourse
2d
Current Updates: Major Developments in Health Sector
This summary highlights major health news, including Bavarian Nordic's UNICEF agreement for mpox vaccines, Pfizer's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Helene death toll rises
'Days of Our Lives' star dies
Vance’s Pennsylvania rally
Hospitalized for burns
'SNL' launches 50th season
Malibu coast earthquake
Chief adviser subpoenaed
Trump to visit Fayetteville
Rescue mission launched
Earth's orbit new asteroid
Faces fine to end Brazil ban
NC dam failure ‘imminent’
Szarewicz case update
Ukrainian drones shot down
ISR strikes Lebanon again
Steward CEO to step down
On Hezbollah leader's killing
Deposition in AI suit
NY ballot appeal rejected
KY sues Express Scripts
Haney sues Garcia
Congestion fee bid denied
High-end brothel plea
Dow closes at record high
Houthis attack US warships
121st loss of the season
Van Gogh paintings attacked
Diocese reaches settlement
Congressional Gold Medal
UNC digital IDs blocked
Human rabies death in MN
ICE: Convicts roaming free
Feedback